TotalMarketCap

Generate Biomedicines

GENBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.643 B

$12.80 -9.61%

Close of 6 Nov 2026

As of 6 Nov 2026, Generate Biomedicines (GENB) has a market capitalization of $1.64B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

128,352,436

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #103Zenas BioPharmaZBIO$1.70B
  2. #104Agios PharmaceuticalsAGIO$1.70B
  3. #105Generate BiomedicinesGENB$1.64B
  4. #106Nurix TherapeuticsNRIX$1.63B
  5. #107Ani PharmaceuticalsANIP$1.60B

What if Generate Biomedicines were worth as much as…

Open the what-if tool →

Gold $28.2T

$219,994.84

Per share 17,187× higher

Bitcoin $1.53T

$11,903.54

Per share 930× higher

Apple $5.02T

$39,078.20

Per share 3,053× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Generate Biomedicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.